ARCT - Arcturus Therapeutics GAAP EPS of -$1.47 beats by $0.16 revenue of $5.8M misses by $5.85M February, 28 2022 04:03 PM Arcturus Therapeutics Ltd. Arcturus Therapeutics press release (NASDAQ:ARCT): Q4 GAAP EPS of -$1.47 beats by $0.16. Revenue of $5.8M (+163.6% Y/Y) misses by $5.85M. For further details see: Arcturus Therapeutics GAAP EPS of -$1.47 beats by $0.16, revenue of $5.8M misses by $5.85M